PYA has released a white paper that offers guidance on how to apply a collaborative and evidence-based approach to due diligence procedures.
PYA, a national healthcare consulting and professional services firm, has released a whitepaper, “Applying a Clinical Model of Care to Transaction Due Diligence.” The white paper explores how assembling a comprehensive team of experts, who work together to assess risk, results in a more complete and collaborative due diligence process for transactions. The paper also highlights best practices for approaching collaborative due diligence, underscores seven high-impact areas, and examines relevant environmental considerations.
According to the white paper: “As many entities without deep healthcare knowledge continue to invest in the industry, the importance of engaging an experienced due diligence team and acting in a collaborative manner to assess multiple areas of enterprise risk continues to increase. An appropriate due diligence approach can ultimately help an entity recognize, understand, and mitigate potential risks. Armed with this knowledge, buyers make more informed decisions.”
This white paper is derived from a PYA article originally published in the AHLA Transactions Guide. The Guide features up-to-date information and legal news and analysis for healthcare attorneys.
PYA’s seasoned transaction advisory team offers a number of services to help clients assess factors that hold significant impact on enterprise risk and the decision of whether to pursue a particular transaction. PYA is committed to a collaborative approach to due diligence services to best meet client needs, using a team of experts from multiple disciplines, including healthcare audit and tax, healthcare operations, clinical coding, managed care and government payer reimbursement, real estate, IT, valuation, and regulatory compliance. This approach allows for streamlined communications and alleviates burdensome client oversight, isolated risk assessments, and divergent due diligence reports.